| # | Drug | Count |
|---|---|---|
| 0 | NIVOLUMAB | 6 |
| 1 | BEVACIZUMAB | 5 |
| 2 | CARBOPLATIN | 5 |
| 3 | TUCATINIB | 5 |
| 4 | LOMUSTINE | 4 |
| 5 | TEMOZOLOMIDE | 4 |
| 6 | CAPECITABINE | 3 |
| 7 | GABAPENTIN | 3 |
| 8 | PEMBROLIZUMAB | 3 |
| 9 | SERTRALINE HYDROCHLORIDE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LOMUSTINE | 4 | 0.0015 |
| 1 | CLINDAMYCIN HYDROCHLORIDE | 1 | 0.0003 |
| 2 | PEGVISOMANT | 1 | 0.0002 |
| 3 | SELENIUM | 1 | 0.0002 |
| 4 | TEMOZOLOMIDE | 4 | 0.0002 |
| 5 | TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM | 1 | 0.0001 |
| 6 | CYCLOBENZAPRINE HYDROCHLORIDE | 1 | 0.0001 |
| 7 | PEGFILGRASTIM | 1 | 0.0001 |
| 8 | OXCARBAZEPINE | 1 | 0.0001 |
| 9 | NIVOLUMAB | 6 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 6 | 0.0001 |
| 1 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 5 | 0.0000 |
| 2 | HER2/neu Receptor Antagonist [EPC] | 2 | 0.0000 |
| 3 | Platinum-based Drug [EPC] | 6 | 0.0000 |
| 4 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |
| 5 | Alkylating Drug [EPC] | 4 | 0.0000 |
| 6 | Cardiac Glycoside [EPC] | 1 | 0.0000 |
| 7 | Arteriolar Vasodilator [EPC] | 1 | 0.0000 |
| 8 | Amide Local Anesthetic [EPC] | 1 | 0.0000 |
| 9 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 1 | 0.0000 |